Rates, types and co-occurrence of emotional and behavioural disorders among perinatally HIV-infected youth in Uganda: the CHAKA study.


Journal

Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 22 05 2018
accepted: 12 02 2019
pubmed: 23 2 2019
medline: 24 5 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

To describe the rates, types and comorbidity of emotional and behavioural disorders among perinatally HIV-infected children and adolescents attending care at five HIV youth clinics in Central and Southwestern Uganda. 1339 CA-HIV attending care at HIV youth clinics in Uganda were interviewed using the DSM-5-based Child and Adolescent Symptom Inventory-5 (CASI-5; caregiver reported) and the Youth Inventory-4R (YI-4R; youth reported). Prevalence, risk factors and comorbidity for psychiatric disorders were estimated using logistic regression models. According to caregiver or youth report, the prevalence of 'any DSM-5 psychiatric disorder' was 17.4% (95% CI 15.4-19.5%), while that of 'any behavioural disorder' was 9.6% (95% CI 8.1-11.2%) and that of 'any emotional disorder' was 11.5% (95% CI 9.9-13.3%). The most prevalent behavioural disorder was attention deficit hyperactivity disorder (5.3%), while the most prevalent emotional disorder was separation anxiety disorder (4.6%). The statistically significant risk factors were: for behavioural disorders, sex (more among males than females) and age group (more among adolescents than among children); for emotional disorders, age group (more among adolescents than among children) and the caregiver's highest educational attainment (more among CA-HIV with caregivers with secondary education and higher, than among CA-HIV with caregivers with no formal education or only primary level education). About a quarter (24.5%) of CA-HIV with at least one emotional disorder and about a third (33.5%) of the CA-HIV with at least one behavioural disorder had a comorbid psychiatric disorder. There was a considerable burden of psychiatric disorders among CA-HIV that spanned a broad spectrum and showed considerable comorbidity.

Identifiants

pubmed: 30788554
doi: 10.1007/s00127-019-01675-0
pii: 10.1007/s00127-019-01675-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

415-425

Subventions

Organisme : Medical Research Council
ID : MC_UP_1204/10
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L004623/1
Pays : United Kingdom
Organisme : Medical Research Council/Department for International Development-African Leadership Award
ID : MR/L004623/1

Références

Compr Psychiatry. 2000 Mar-Apr;41(2 Suppl 1):1-7
pubmed: 10746897
Psychosom Med. 2005 Nov-Dec;67(6):1013-21
pubmed: 16314608
Br J Psychiatry. 2006 Dec;189:547-55
pubmed: 17139040
AIDS. 2007 Oct;21 Suppl 5:S55-63
pubmed: 18090270
J Child Psychol Psychiatry. 2009 Sep;50(9):1131-8
pubmed: 19298479
Brain Behav Immun. 2009 May;23(4):434-45
pubmed: 19486650
East Afr Med J. 2009 Jan;86(1):16-24
pubmed: 19530544
J Dev Behav Pediatr. 2010 Feb-Mar;31(2):116-28
pubmed: 20110828
AIDS Behav. 2011 Aug;15(6):1161-70
pubmed: 20711651
Psychiatry (Edgmont). 2007 May;4(5):35-40
pubmed: 20806028
BMC Psychiatry. 2011 Jun 08;11:97
pubmed: 21651809
AIDS Care. 2012;24(7):836-42
pubmed: 22292795
Arch Pediatr Adolesc Med. 2012 Jun 1;166(6):528-35
pubmed: 22312169
Ment Health Fam Med. 2009 Mar;6(1):37-42
pubmed: 22477886
AIDS Care. 2012;24(8):953-62
pubmed: 22519762
AIDS Behav. 2012 Nov;16(8):2119-43
pubmed: 22644066
J Int AIDS Soc. 2013 Jun 18;16:18593
pubmed: 23782478
PLoS One. 2013 Jul 23;8(7):e70254
pubmed: 23894625
Trials. 2014 Jun 25;15:248
pubmed: 24962086
Trop Med Int Health. 2014 Dec;19(12):1392-6
pubmed: 25319189
AIDS Care. 2015;27 Suppl 1:6-17
pubmed: 26616121
AIDS Behav. 2017 Jun;21(6):1641-1654
pubmed: 27722834
Trop Doct. 2017 Oct;47(4):347-354
pubmed: 28766999
Global Health. 2017 Sep 12;13(1):72
pubmed: 28899415
BMC Psychiatry. 2017 Sep 22;17(1):336
pubmed: 28938881
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):136-143
pubmed: 29424787

Auteurs

Eugene Kinyanda (E)

Mental Health Project, MRC/UVRI & LSHTM Uganda Research Unit/Senior Wellcome Trust Fellowship, P.O. Box 49, Entebbe, Uganda. Eugene.Kinyanda@mrcuganda.org.
Department of Psychiatry, Makerere College of Health Sciences, P.O. Box 7072, Kampala, Uganda. Eugene.Kinyanda@mrcuganda.org.

Tatiana T Salisbury (TT)

Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Camberwell, London, SE5 8AF, UK.

Jonathan Levin (J)

School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Private Bag 3, Johannesburg, WITS 2050, South Africa.

Noeline Nakasujja (N)

Department of Psychiatry, Makerere College of Health Sciences, P.O. Box 7072, Kampala, Uganda.

Richard S Mpango (RS)

Mental Health Project, MRC/UVRI & LSHTM Uganda Research Unit/Senior Wellcome Trust Fellowship, P.O. Box 49, Entebbe, Uganda.

Catherine Abbo (C)

Department of Psychiatry, Makerere College of Health Sciences, P.O. Box 7072, Kampala, Uganda.

Soraya Seedat (S)

Department of Psychiatry, Stellenbosch University, Private Bag X1, Matieland, 7602, South Africa.

Ricardo Araya (R)

Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 16 De Crespigny Park, Camberwell, London, SE5 8AF, UK.

Seggane Musisi (S)

Department of Psychiatry, Makerere College of Health Sciences, P.O. Box 7072, Kampala, Uganda.

Kenneth D Gadow (KD)

Department of Psychiatry, Stony Brook University, 01 Nicolls Rd, Stony Brook, New York, 11794, USA.

Vikram Patel (V)

Department of Global Health and Social Medicine, Harvard Medical School, A-111, 25 Shattuck St, Boston, MA, 02115, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH